TRIDENT UNIVERSITY

Module 4 Case Assignment

BHM320: Management of Health Programs

Dr. Eileen Ringerman

8 Jul 2013

Module 4 Case Assignment Questions:
1) Briefly discuss the program and what led to its implementation.
2) In general, what are the different types of program evaluation available to a manager?
3) What are the advantages and disadvantages of each one?
4) What program evaluation was used in this case?
5) Based upon the data and other information in the article, was this the best approach?
6) What did the evaluation reveal about the program? Did it achieve what it was supposed to? Should it be continued or even replicated elsewhere?

The article, Implementation of an antimicrobial …show more content…

Key informant interviews have a planned set of questions on the topic of interest and is useful to when candid information about sensitive topics are needed. The disadvantage to this process is that you’re limiting the amount of input you will receive. Focus groups, interviews and observation advantages are that (1) help figure out major program problems that cannot be explained my more formal methods of analysis, (2) evaluator may see things that participants and staff may not see, (3) evaluator can learn about things which participants or staff may be unwilling to reveal in more formal methods and (4) when a main purpose is to generate recommendations. Disadvantages with this process is (1) evaluators subjective views can introduce error, (2) focus of the evaluator is only on what is observed at one time in place and (3) focus groups could be dominated by one individual and their point of view. In the article, Implementation of an antimicrobial stewardship program in a rural hospital the program evaluation that the managers used was analysis of administrative data to grade their AMS program. The primary endpoints to be measured was (1) the number of interventions after the review of antimicrobial therapy by the clinical pharmacist, (2) the rate of empiric antimicrobial streamlining on the basis of culture results or elimination of redundant therapy, (3) third the percentage agreement between pharmacist and ID physician